Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pholcodine is an opioid antitussive (cough suppressant) used for the temporary relief of non-productive (dry) cough. It acts primarily on the central nervous system by depressing the cough reflex through a direct effect on the cough center in the medulla oblongata. Pholcodine has a mild sedative effect but little or no analgesic properties. It has been widely used since the 1950s and is available in various formulations such as syrups, oral solutions, capsules, and lozenges under different brand names and generics. The drug is not approved in some countries including the United States and Canada[1][2][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pholcodine.